These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34406563)

  • 1. Risk factors for surgical site infection and association of surgical site infection with survival of lower rectal cancer patients without clinical lateral pelvic lymph node metastasis (clinical Stage II/III): Analysis of data from JCOG0212.
    Katsumata K; Enomoto M; Ishizaki T; Fujita S; Kanemitsu Y; Ito M; Shiomi A; Komori K; Ohue M; Ota M; Akazai Y; Shiozawa M; Yamaguchi T; Bando H; Sekimoto M; Kobatake T; Machida R; Akasu T; Moriya Y;
    Clin Exp Metastasis; 2021 Oct; 38(5):459-466. PubMed ID: 34406563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesorectal Excision With or Without Lateral Lymph Node Dissection for Clinical Stage II/III Lower Rectal Cancer (JCOG0212): A Multicenter, Randomized Controlled, Noninferiority Trial.
    Fujita S; Mizusawa J; Kanemitsu Y; Ito M; Kinugasa Y; Komori K; Ohue M; Ota M; Akazai Y; Shiozawa M; Yamaguchi T; Bandou H; Katsumata K; Murata K; Akagi Y; Takiguchi N; Saida Y; Nakamura K; Fukuda H; Akasu T; Moriya Y;
    Ann Surg; 2017 Aug; 266(2):201-207. PubMed ID: 28288057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial.
    Fujita S; Akasu T; Mizusawa J; Saito N; Kinugasa Y; Kanemitsu Y; Ohue M; Fujii S; Shiozawa M; Yamaguchi T; Moriya Y;
    Lancet Oncol; 2012 Jun; 13(6):616-21. PubMed ID: 22591948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive factors of pathological lateral pelvic lymph node metastasis in patients without clinical lateral pelvic lymph node metastasis (clinical stage II/III): The analysis of data from the clinical trial (JCOG0212).
    Komori K; Fujita S; Mizusawa J; Kanemitsu Y; Ito M; Shiomi A; Ohue M; Ota M; Akazai Y; Shiozawa M; Yamaguchi T; Bandou H; Katsumata K; Kinugasa Y; Takii Y; Akasu T; Moriya Y;
    Eur J Surg Oncol; 2019 Mar; 45(3):336-340. PubMed ID: 30477950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up of the randomized trial of mesorectal excision with or without lateral lymph node dissection in rectal cancer (JCOG0212).
    Tsukamoto S; Fujita S; Ota M; Mizusawa J; Shida D; Kanemitsu Y; Ito M; Shiomi A; Komori K; Ohue M; Akazai Y; Shiozawa M; Yamaguchi T; Bando H; Tsuchida A; Okamura S; Akagi Y; Takiguchi N; Saida Y; Akasu T; Moriya Y;
    Br J Surg; 2020 Apr; 107(5):586-594. PubMed ID: 32162301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective lateral lymph node dissection after neoadjuvant chemoradiotherapy in rectal cancer.
    Chen JN; Liu Z; Wang ZJ; Mei SW; Shen HY; Li J; Pei W; Wang Z; Wang XS; Yu J; Liu Q
    World J Gastroenterol; 2020 Jun; 26(21):2877-2888. PubMed ID: 32550762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary dysfunction after rectal cancer surgery: Results from a randomized trial comparing mesorectal excision with and without lateral lymph node dissection for clinical stage II or III lower rectal cancer (Japan Clinical Oncology Group Study, JCOG0212).
    Ito M; Kobayashi A; Fujita S; Mizusawa J; Kanemitsu Y; Kinugasa Y; Komori K; Ohue M; Ota M; Akazai Y; Shiozawa M; Yamaguchi T; Akasu T; Moriya Y;
    Eur J Surg Oncol; 2018 Apr; 44(4):463-468. PubMed ID: 29428473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Male sexual dysfunction after rectal cancer surgery: Results of a randomized trial comparing mesorectal excision with and without lateral lymph node dissection for patients with lower rectal cancer: Japan Clinical Oncology Group Study JCOG0212.
    Saito S; Fujita S; Mizusawa J; Kanemitsu Y; Saito N; Kinugasa Y; Akazai Y; Ota M; Ohue M; Komori K; Shiozawa M; Yamaguchi T; Akasu T; Moriya Y;
    Eur J Surg Oncol; 2016 Dec; 42(12):1851-1858. PubMed ID: 27519616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laparoscopic lateral pelvic lymph node dissection for lower rectal cancer treated with preoperative chemoradiotherapy.
    Matsuda T; Hasegawa H; Yamashita K; Tanaka T; Yamamoto M; Kanaji S; Oshikiri T; Nakamura T; Sumi Y; Suzuki S; Kakeji Y
    Surg Endosc; 2020 Mar; 34(3):1425-1431. PubMed ID: 31628619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploratory analysis of lateral pelvic sentinel lymph node status for optimal management of laparoscopic lateral lymph node dissection in advanced lower rectal cancer without suspected lateral lymph node metastasis.
    Yasui M; Ohue M; Noura S; Miyoshi N; Takahashi Y; Matsuda C; Nishimura J; Haraguchi N; Ushigome H; Nakai N; Fujino S; Sugimura K; Wada H; Takahashi H; Omori T; Miyata H
    BMC Cancer; 2021 Aug; 21(1):911. PubMed ID: 34380428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postoperative morbidity and mortality after mesorectal excision with laparoscopic versus conventional open lateral lymph node dissection for advanced rectal cancer: A meta-analysis.
    Du R; Zhou J; Li D; Zhang Q; Liu J; Ma C; Wang L; Wang D
    Asian J Surg; 2021 Jan; 44(1):26-35. PubMed ID: 32798083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Thirty years' changes of the strategy of lateral lymph node dissection in low rectal cancer: treatment experience and prognostic analysis of 289 cases in one single center].
    Tang JQ; Li HY; Liu T; Zhang JL; Zuo S; Sun L; Wu YC; Jiang Y; Chen GW; Wu T; Wan YL; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Oct; 24(10):889-896. PubMed ID: 34674464
    [No Abstract]   [Full Text] [Related]  

  • 13. Outcomes and prognostic factors of selective lateral pelvic lymph node dissection with preoperative chemoradiotherapy for locally advanced rectal cancer.
    Matsuda T; Sumi Y; Yamashita K; Hasegawa H; Yamamoto M; Matsuda Y; Kanaji S; Oshikiri T; Nakamura T; Suzuki S; Kakeji Y
    Int J Colorectal Dis; 2018 Apr; 33(4):367-374. PubMed ID: 29442155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential impact of lateral lymph node dissection (LLND) for low rectal cancer on prognoses and local control: A comparison of 2 high-volume centers in Japan that employ different policies concerning LLND.
    Kanemitsu Y; Komori K; Shida D; Ochiai H; Tsukamoto S; Kinoshita T; Moriya Y
    Surgery; 2017 Aug; 162(2):303-314. PubMed ID: 28366499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of surgery alone for lower rectal cancer with and without pelvic sidewall dissection.
    Kobayashi H; Mochizuki H; Kato T; Mori T; Kameoka S; Shirouzu K; Sugihara K
    Dis Colon Rectum; 2009 Apr; 52(4):567-76. PubMed ID: 19404054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of lateral pelvic lymph node dissection with total mesorectal excision in treatment of rectal cancer: A systematic review and meta-analysis.
    Emile SH; Elfeki H; Shalaby M; Sakr A; Kim NK
    Surgery; 2021 May; 169(5):1005-1015. PubMed ID: 33317903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative and postoperative prognostic factors of patients with stage II/III lower rectal cancer without neoadjuvant therapy in the clinical trial (JCOG0212).
    Ohue M; Fujita S; Mizusawa J; Kanemitsu Y; Hamaguchi T; Tsukamoto S; Noura S; Yasui M; Itoh M; Shiomi A; Komori K; Watanabe J; Akazai Y; Shiozawa M; Yamaguchi T; Bandou H; Katsumata K; Moriya Y
    Jpn J Clin Oncol; 2022 Feb; 52(2):114-121. PubMed ID: 34865105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Prognostic Significance of Isolated Tumor Cells Detected Within Lateral Lymph Nodes in Rectal Cancer Patients After Laparoscopic Lateral Lymph Node Dissection.
    Yang X; Hu T; Gu C; Yang S; Jiang D; Deng X; Wang Z; Zhou Z
    J Laparoendosc Adv Surg Tech A; 2019 Nov; 29(11):1462-1468. PubMed ID: 31539301
    [No Abstract]   [Full Text] [Related]  

  • 19. Short- and long-term outcomes of laparoscopic versus open lateral lymph node dissection for locally advanced middle/lower rectal cancer using a propensity score-matched analysis.
    Watanabe J; Ishibe A; Suwa Y; Ozawa M; Nakagawa K; Suwa H; Ota M; Kunisaki C; Endo I
    Surg Endosc; 2021 Aug; 35(8):4427-4435. PubMed ID: 32875413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term outcomes of laparoscopic lateral pelvic node dissection for advanced lower rectal cancer.
    Tokuhara K; Hishikawa H; Yoshida T; Ueyama Y; Yoshioka K; Sekimoto M
    Surg Endosc; 2021 Apr; 35(4):1572-1578. PubMed ID: 32246236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.